Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 1381-1393

  Otsuka, Ikuo ^a   Watanabe, Yuichiro ^b   Hishimoto, Akitoyo ^a   Boku, Shuken ^a   Mouri, Kentaro ^a   Shiroiwa, Kyoichi ^a   Okazaki, Satoshi ^a   Nunokawa, Ayako ^b   Shirakawa, Osamu ^c   Someya, Toshiyuki ^b   Sora, Ichiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

CDH13; Haplotype; Promoter region; SNP

Indexed keywords

ADULT; ARTICLE; CADHERIN 13 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84933505606     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S84736     Document Type: Article

References (36)

1. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187-1192.
2. Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004;363(9426):2063-2072.
3. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13(8):537-551.
4. McCarley RW, Wible CG, Frumin M, et al. MRI anatomy of schizophrenia. Biol Psychiatry. 1999;45(9):1099-1119.
5. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49(1-2):1-52.
6. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122(Pt4):593-624.
7. Gregório SP, Sallet PC, Do KA, Lin E, Gattaz WF, Dias-Neto E. Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res. 2009;165(1-2):1-9.
8. Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull. 2009;35(3):509-527.
9. Takeichi M. The cadherin superfamily in neuronal connections and interactions. Nat Rev Neurosci. 2007;8(1):11-20.
10. Hirano S, Takeichi M. Cadherins in brain morphogenesis and wiring. Physiol Rev. 2012;92(2):597-634.
11. Pedrosa E, Stefanescu R, Margolis B, et al. Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia. Schizophr Res. 2008;102(1-3):210-219.
12. Redies C, Hertel N, Hübner CA. Cadherins and neuropsychiatric disorders. Brain Res. 2012;1470:130-144.
13. Rivero O, Sich S, Popp S, Schmitt A, Franke B, Lesch KP. Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. Eur Neuropsychopharmacol. 2013;23(6):492-507.
14. Neale BM, Lasky-Su J, Anney R, et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1337-1344.
15. Zhou K, Dempfle A, Arcos-Burgos M, et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1392-1398.
16. Terracciano A, Tanaka T, Sutin AR, et al. Genome-wide association scan of trait depression. Biol Psychiatry. 2010;68(9):811-817.
17. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009;459:528-533.
18. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011;70(5):863-885.
19. Treutlein J, Cichon S, Ridinger M, et al. Genome-wide association study of alcohol dependence. Arch Gen Psychiatry. 2009;66(77):773-784.
20. Uhl GR, Drgon T, Johnson C, et al. Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 2010;11(3):357-367.
21. Uhl GR, Drgon T, Liu QR, et al. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry. 2008;65(3):345-355.
22. Børglum AD, Demontis D, Grove J, et al; GROUP investigators 10. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry. 2014;19(3):325-333.
23. Dixon AL, Liang L, Moffatt MF, et al. A genome-wide association study of global gene expression. Nat Genet. 2007;39:1202-1207.
24. Hirakawa M, Tanaka T, Hashimoto, et al. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res. 2002;30: 158-162.
25. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res. 2006;84(1):29-35.
26. Okazaki S, Watanabe Y, Hishimoto A, et al. Association analysis of putative cis-acting polymorphisms of interleukin-19 gene with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:151-156.
27. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, text revision (DSM-IV TR). American Psychiatric Association Press. 2000.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265.
29. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19(6):589-601.
30. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580-585.
31. Benes FM. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology. 2010;35(1):239-257.
32. Paradis S, Harrar DB, Lin Y, et al. An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. Neuron. 2007;53(2):217-232.
33. Yizhar O, Fenno LE, Prigge M, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477(7363):171-178.
34. Mao W, Watanabe T, Cho S, et al. Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons. Eur J Neurosci. 2015;41(8):1025-1035.
35. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-427.
36. Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics. 1999;15(7-8):622-630.